Phase 2 Multi‐Arm Study of Magrolimab Combinations in Patients With Acute Myeloid Leukaemia

Phase 2 Multi‐Arm Study of Magrolimab Combinations in Patients With Acute Myeloid Leukaemia

ABSTRACT Introduction This phase 2 study evaluated magrolimab+venetoclax (VEN)+azacitidine (AZA) in untreated, unfit acute myeloid leukaemia (AML) and magrolimab+mitoxantrone+etoposide+cytarabine in relapsed/refractory (R/R) AML. Methods Endpoints included complete remission rate (CRR), overall resp...

Full description

Saved in:
Bibliographic Details
Main Authors: Gabriel N. Mannis, Camille N. Abboud, Naval G. Daver, Guru Subramanian Guru Murthy, Eunice S. Wang, Terrence J. Bradley, George Yaghmour, Pankit Vachhani, Suresh Kumar Balasubramanian, Chong Chyn Chua, Chun Yew Fong, Adam S. Asch, Mei Dong, Shuang Li, Taravat Bagheri, Parul Doshi, Paresh Vyas, Monzr M. Al Malki
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:eJHaem
Subjects:
AML | chemotherapy | clinical research | haematological malignancy | haematological oncology | immunotherapy
Online Access:https://doi.org/10.1002/jha2.70051
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/jha2.70051

Similar Items